Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay).

BMC clinical pharmacology - 24 Oct 2006

Panchabhai Tanmay S, Noronha Shaun F, Davis Sanish, Shinde Vishal M, Kshirsagar Nilima A, Gogtay Nithya J

Abstract excerpt

BACKGROUND: Inherited differences in the metabolism and disposition of drugs, and genetic polymorphisms in the targets of drug therapy (e.g., receptors), can greatly influence efficacy and toxicity of medications. Marked interethnic differences in CYP2C19 (a member of the cytochrome P-450 enzyme...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Asian People
Share to Cytochrome P-450 CYP2C19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme Activation

Share to Mixed Function Oxygenases

Share to Multigene Family

Share to Polymorphism, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 17062149
DOI: 10.1186/1472-6904-6-8
PMCID: PMC1630702

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17062149-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the activity of CYP2C19 in Gujrati and Marwadi subjects living in Mumbai (Bombay).PMID 17062149Read ↗

Evaluation of cytochrome P450 2C9 activity in normal, healthy, adult Western Indian population by both phenotyping and genotyping.Semantic proximity Read ↗

Estimation of polymorphisms in the drug-metabolizing enzyme, cytochrome P450 2C19 gene in six major ethnicities of Pakistan.Semantic proximity Read ↗

Major CYP450 Polymorphism among Saudi Patients.Semantic proximity Read ↗

Correlation between omeprazole hydroxylase and CYP2C19 genotype in North Indians.Semantic proximity Read ↗

CYP2C19 polymorphism as a predictor of personalized therapy in South Indian population.Semantic proximity Read ↗

CYP2C19 genetic mutations in North Indians.Semantic proximity Read ↗

Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians.Semantic proximity Read ↗

Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.Semantic proximity Read ↗

Traditional Medicine to Modern Pharmacogenomics: Ayurveda<i>Prakriti</i>Type and CYP2C19 Gene Polymorphism Associated with the Metabolic VariabilitySemantic proximity Read ↗

Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.Semantic proximity Read ↗

High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.Semantic proximity Read ↗

Genetic polymorphism of the hepatic cytochrome P450 2C19 in north Indian subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.